About US
Contact us
-
FDA Clears GeNO LLC Investigational New Drug Application for Nitric Oxide Delivery SystemGeNO LLC, a privately held, advanced development-stage technology company, recently announced that the US FDA has granted clearance of its Investigational New Drug (IND) application for its st2010/3/26
-
DPT Executes Strategic Initiative to Create New Centers of ExcellenceDPT Laboratories, Ltd., a pharmaceutical contract development and manufacturing organization, recently announced a restructuring of its facilities to create three new Centers of Excellence to2010/3/26
-
Direct Powder Blends for TablettingDate: Tuesday, April 27, 2010 Time: 12:00 PM (Noon) – 2:00 PM EDT Presented by: John A. McCarty Moderated by: Matthew Knopp, editor of Tablets & Capsules Description: Eliminate the need for wet or2010/3/26
-
Compugen Announces Discovery Platform to Predict Cell-Penetrating Peptides for Drug DeliveryCompugen Ltd. recently announced the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell-penetrating peptides. Compugen also2010/3/25
-
BENEO GmbH Enters Japan With Multifunctional Bulk ExcipientThe manufacturer BENEO, member of the Südzucker Group, recently announced that the Pharmaceutical and Medical Devices Agency (PMDA) in Japan has granted the first license for the manufacture a2010/3/25
-
INNERCAP Granted US Patent on Multi-Phase, Multi-Compartment Capsular Delivery Apparatus & Methods for Using the SameINNERCAP Technologies, Inc., an international drug delivery and specialty pharmaceutical company, recently announced the grant of US Patent No. 7,670,612 titled Multi-Phase, Multi-Compar2010/3/25
-
VESTAKEEP® PEEK for ball sockets combines high-temperature stability with excellent tribological propertiesVESTAKEEP® PEEK, made by Essen, Germany-based Evonik Industries, dramatically reduces not only friction in ball bearings. A Japanese automotive supplier has now found that it minimizes torque and2010/3/24
-
Adaptive Design Clinical Trials for Drugs and Biologics20100324(2).rar source: web of FDA2010/3/24
-
Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format20100324(1).rar source: web of FDA2010/3/24
-
GW Pharma Updates On Sativex Oromucosal Spray Regulatory ProcessGW Pharmaceuticals (GW) has provided an update on the progress of its regulatory submission for Sativex Oromucosal Spray for the treatment of the symptoms of spasticity due to Multiple Sclerosis. The2010/3/23